VivoSim Labs Statistics

Total Valuation

VivoSim Labs has a market cap or net worth of GBP 3.37 million. The enterprise value is -4.23 million.

Market Cap	3.37M
Enterprise Value	-4.23M

Important Dates

The next estimated earnings date is Tuesday, August 19, 2025.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.78M
Shares Outstanding	n/a
Shares Change (YoY)	+92.06%
Shares Change (QoQ)	+8.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	30.26
PB Ratio	0.42
P/TBV Ratio	0.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	2.20
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.58

Financial Position

The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.09.

Current Ratio	3.25
Quick Ratio	3.04
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	-1,261.58

Financial Efficiency

Return on equity (ROE) is -35.31% and return on invested capital (ROIC) is -95.99%.

Return on Equity (ROE)	-35.31%
Return on Assets (ROA)	-75.10%
Return on Invested Capital (ROIC)	-95.99%
Return on Capital Employed (ROCE)	-115.61%
Revenue Per Employee	12,384
Profits Per Employee	-213,965
Employee Count	13
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, VivoSim Labs has paid 1,548 in taxes.

Income Tax	1,548
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.86% in the last 52 weeks. The beta is 1.13, so VivoSim Labs's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	-74.86%
50-Day Moving Average	5.35
200-Day Moving Average	10.99
Relative Strength Index (RSI)	38.65
Average Volume (20 Days)	9,214

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.23

Income Statement

In the last 12 months, VivoSim Labs had revenue of GBP 111,455 and -1.93 million in losses. Loss per share was -1.32.

Revenue	111,455
Gross Profit	-3.78M
Operating Income	-9.76M
Pretax Income	-1.92M
Net Income	-1.93M
EBITDA	-9.56M
EBIT	-9.76M
Loss Per Share	-1.32

Full Income Statement

Balance Sheet

The company has 8.76 million in cash and 729,099 in debt, giving a net cash position of 8.03 million.

Cash & Cash Equivalents	8.76M
Total Debt	729,099
Net Cash	8.03M
Net Cash Per Share	n/a
Equity (Book Value)	8.12M
Book Value Per Share	4.28
Working Capital	6.50M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.32 million and capital expenditures -10,062, giving a free cash flow of -7.33 million.

Operating Cash Flow	-7.32M
Capital Expenditures	-10,062
Free Cash Flow	-7.33M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-8,761.08%
Pretax Margin	-1,726.38%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VivoSim Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-92.06%
Shareholder Yield	n/a
Earnings Yield	-57.10%
FCF Yield	-217.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 19, 2020. It was a reverse split with a ratio of 0.05.

Last Split Date	Aug 19, 2020
Split Type	Reverse
Split Ratio	0.05

Scores

VivoSim Labs has an Altman Z-Score of -33.61 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-33.61
Piotroski F-Score	3